微创主动脉瓣与二尖瓣术后早期出院研究
单中心回顾性研究分析2012-2019年择期无并发症微创主动脉瓣或二尖瓣手术成年患者,按术后住院时长分为早期出院(≤3天)与晚期出院(>3天),发现早期出院比例随时间增加,早期出院与较低直接费用相关,调整后30天死亡率和再入院率相当。
要点
- 择期无并发症微创瓣膜术后25%患者早期出院(≤3天),比例逐年增加。
- 早期出院者调整后30天死亡率和再入院率与晚期出院者相当。
- 早期出院者中位直接费用显著更低($20,046 vs $22,124)。
核心结论
- 在经过良好选择的患者中,微创瓣膜术后早期出院与较低费用相关,且术后结局相当。
- 约五分之一的术后第3天仍住院患者可能适合更早出院。
研究设计与样本
- 单中心回顾性研究,纳入2012-2019年择期无并发症微创主动脉瓣或二尖瓣手术成年患者,共1262例连续患者中618例符合条件。
- 按术后住院时长分为早期出院(≤3天)和晚期出院(>3天),采用多因素logistic回归和1:1倾向性评分匹配分析。
主要发现
- 618例择期无并发症患者中25%(n=162)早期出院,早期出院比例随时间增加(趋势P<.05)。
- 充血性心力衰竭史、卒中史、吸烟史及较高STS预测死亡风险评分负向预测早期出院(P<.05)。
- 倾向性评分匹配识别101例(22%)晚期出院患者与早期出院患者健康状态相似。
- 调整后30天死亡率和再入院率在两组间相当。
- 早期出院组中位直接费用显著低于晚期出院组($20,046 vs $22,124,P<.05)。
临床怎么用
- 对于经过选择的择期无并发症微创瓣膜手术患者,可考虑术后3天内早期出院以降低费用。
- 术后第3天仍住院患者中约五分之一可能适合更早出院,需评估个体情况。
局限性
- 单中心回顾性研究,结果外推需谨慎。
- 早期出院组与晚期出院组基线特征可能存在差异,尽管采用倾向性评分匹配。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We investigated patient outcomes in relation to their postoperative length of stay after minimally invasive valve surgery. METHODS: All adults who survived elective, uncomplicated minimally invasive aortic or mitral valve surgery at a single center between 2012 and 2019 were classified by postoperative length of stay: early discharge (≤3 days) or late discharge (>3 days). The trend in early discharge was investigated over the study period, predictors of early discharge were identified using multivariate logistic regression modeling, and 1:1 propensity score matching was used to determine which patients in the late-discharge cohort had similar health to patients discharged early. Adjusted outcomes of 30-day mortality, readmission, and direct costs were analyzed. RESULTS: Among 1262 consecutive patients undergoing minimally invasive valve surgery, 618 were elective and uncomplicated, 25% (n = 162) of whom were discharged early. The proportion of early-discharge patients increased over time (P for trend < .05). A history of congestive heart failure, stroke, or smoking and higher Society of Thoracic Surgeons predictive risk of mortality score negatively predicted early discharge (P < .05). Propensity score matching identified 101 (22%) late-discharge patients comparable with early-discharge patients. Adjusted 30-day mortality and readmission rates were comparable between cohorts. The median direct costs per patient ($20,046 vs $22,124, P < .05) were significantly lower in the early-discharge cohort. CONCLUSIONS: In well-selected patients early discharge after minimally invasive valve surgery was associated with lower costs but comparable postoperative outcomes. About one-fifth of patients who remain in the hospital beyond postoperative day 3 may be candidates for earlier discharge.
引用
- Sabatino ME, Okoh AK, Chao JC, et al. Early Discharge After Minimally Invasive Aortic and Mitral Valve Surgery. Ann Thorac Surg. 2021. PMID: 34419437. doi:10.1016/j.athoracsur.2021.07.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。